Thiogenesis Therapeutics, Corp. is very pleased to announce that, further to its news release of December 18, 2023, it has closed a second and final tranche of its non-brokered private placement,.
Further to its news release of November 20, 2023, Thiogenesis Therapeutics, Corp. is very pleased to announce that it has closed a non-brokered private placement through the issuance of 5,584,167.